000 01496 a2200469 4500
005 20250516220500.0
264 0 _c20140902
008 201409s 0 0 eng d
022 _a1423-0232
024 7 _a10.1159/000360295
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMack, Frederic
245 0 0 _aCarmustine (BCNU) plus Teniposide (VM26) in recurrent malignant glioma.
_h[electronic resource]
260 _bOncology
_c2014
300 _a369-72 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xtherapeutic use
650 0 4 _aBrain Neoplasms
_xdrug therapy
650 0 4 _aCarmustine
_xadministration & dosage
650 0 4 _aDisease-Free Survival
650 0 4 _aFemale
650 0 4 _aGlioma
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aKaplan-Meier Estimate
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Recurrence, Local
_xdrug therapy
650 0 4 _aRetrospective Studies
650 0 4 _aTeniposide
_xadministration & dosage
700 1 _aSchäfer, Niklas
700 1 _aKebir, Sied
700 1 _aStuplich, Moritz
700 1 _aSchaub, Christina
700 1 _aNiessen, Michael
700 1 _aScheffler, Björn
700 1 _aHerrlinger, Ulrich
700 1 _aGlas, Martin
773 0 _tOncology
_gvol. 86
_gno. 5-6
_gp. 369-72
856 4 0 _uhttps://doi.org/10.1159/000360295
_zAvailable from publisher's website
999 _c23931605
_d23931605